{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:39:25Z","timestamp":1790419165277,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronavirus started in March 2020. The conclusions from numerous studies indicate that people with comorbidities, such as arterial hypertension, diabetes, obesity, underlying cardiovascular disease, are particularly vulnerable to the severe course of COVID-19. The available data also suggest that patients with dyslipidemia, the most common risk factor of cardiovascular diseases, are also at greater risk of severe course of COVID-19. On the other hand, it has been shown that COVID-19 infection has an influence on lipid profile leading to dyslipidemia, which might require appropriate treatment. Owing to antiviral, anti-inflammatory, immunomodulatory, and cardioprotective activity, statin therapy has been considered as valuable tool to improve COVID-19 outcomes. Numerous observational studies have shown potential beneficial effects of lipid-lowering treatment on the course of COVID-19 with significant improved prognosis and reduced mortality.<\/jats:p>","DOI":"10.1186\/s12944-021-01563-0","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T23:15:52Z","timestamp":1635117352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8073-6664","authenticated-orcid":false,"given":"Stanis\u0142aw","family":"Surma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-2453","authenticated-orcid":false,"given":"Joanna","family":"Lewek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"issue":"6","key":"1563_CR1","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","volume":"6","author":"A D\u00f6mling","year":"2020","unstructured":"D\u00f6mling A, Gao L. Chemistry and biology of SARS-CoV-2. Chem. 2020;6(6):1283\u201395. https:\/\/doi.org\/10.1016\/j.chempr.2020.04.023.","journal-title":"Chem"},{"key":"1563_CR2","doi-asserted-by":"publisher","first-page":"110493","DOI":"10.1016\/j.biopha.2020.110493","volume":"129","author":"W Dos Santos","year":"2020","unstructured":"Dos Santos W. Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomed Pharmacother. 2020;129:110493. https:\/\/doi.org\/10.1016\/j.biopha.2020.110493.","journal-title":"Biomed Pharmacother"},{"key":"1563_CR3","doi-asserted-by":"crossref","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Res Sq. 2021:rs.3.rs-266574.","DOI":"10.21203\/rs.3.rs-266574\/v1"},{"key":"1563_CR4","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.eclinm.2021.100899","volume":"36","author":"FM Iqbal","year":"2021","unstructured":"Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100899.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1563_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/s12879-021-06369-0","volume":"21","author":"C Shi","year":"2021","unstructured":"Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, et al. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):663. https:\/\/doi.org\/10.1186\/s12879-021-06369-0.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1563_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/heartjnl-2020-317901","volume":"107","author":"S Bae","year":"2021","unstructured":"Bae S, Kim SR, Kim M-N, Shim WJ, Park S-M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107(5):373\u201380. https:\/\/doi.org\/10.1136\/heartjnl-2020-317901.","journal-title":"Heart"},{"issue":"6","key":"1563_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/jcm9061909","volume":"9","author":"D Radenkovic","year":"2020","unstructured":"Radenkovic D, Chawla S, Pirro M, Sahebkar A, Banach M. Cholesterol in relation to COVID-19: should we care about it? J Clin Med. 2020;9(6):1909. https:\/\/doi.org\/10.3390\/jcm9061909.","journal-title":"J Clin Med"},{"key":"1563_CR8","doi-asserted-by":"publisher","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021. https:\/\/doi.org\/10.1038\/s41569-021-00541-4.","DOI":"10.1038\/s41569-021-00541-4"},{"issue":"2","key":"1563_CR9","doi-asserted-by":"publisher","first-page":"158849","DOI":"10.1016\/j.bbalip.2020.158849","volume":"2021","author":"E Ko\u010dar","year":"1866","unstructured":"Ko\u010dar E, Re\u017een T, Rozman D. Cholesterol, lipoproteins, and COVID-19: basic concepts and clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids. 1866;2021(2):158849. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158849.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"1563_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.virol.2008.08.026","volume":"381","author":"J Glende","year":"2008","unstructured":"Glende J, Schwegmann-Wessels C, Al-Falah M, et al. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology. 2008;381(2):215\u201321. https:\/\/doi.org\/10.1016\/j.virol.2008.08.026.","journal-title":"Virology"},{"issue":"6517","key":"1563_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1126\/science.abd3255","volume":"370","author":"C Toelzer","year":"2020","unstructured":"Toelzer C, Gupta K, Yadav SKN, Borucu U, Davidson AD, Kavanagh Williamson M, et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science. 2020;370(6517):725\u201330. https:\/\/doi.org\/10.1126\/science.abd3255.","journal-title":"Science"},{"issue":"13","key":"1563_CR12","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1002\/anie.202015639","volume":"60","author":"DK Shoemark","year":"2021","unstructured":"Shoemark DK, Colenso CK, Toelzer C, Gupta K, Sessions RB, Davidson AD, et al. Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free fatty acid pocket of the SARS-CoV-2 spike protein. Angew Chem Int Ed Engl. 2021;60(13):7098\u2013110. https:\/\/doi.org\/10.1002\/anie.202015639.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1563_CR13","doi-asserted-by":"publisher","unstructured":"Wei C, Wan L, Zhang Y, et al. Cholesterol metabolism \u2014 Impact for SARS-CoV-2 infection prognosis, entry, and antiviral therapies. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.16.20068528.","DOI":"10.1101\/2020.04.16.20068528"},{"key":"1563_CR14","doi-asserted-by":"publisher","unstructured":"Atmosudigdo IS, Pranata R, Lim MA, Henrina J, Yonas E, Vania R, et al. Dyslipidemia increases the risk of severe COVID-19: a systematic review, meta-analysis, and meta-regression. J Clin Exp Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.jceh.2021.01.007.","DOI":"10.1016\/j.jceh.2021.01.007"},{"issue":"5","key":"1563_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.dsx.2020.07.054","volume":"14","author":"TI Hariyanto","year":"2020","unstructured":"Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1463\u20135. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.054.","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"1563_CR16","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s10067-020-05301-2","volume":"39","author":"CS Santos","year":"2020","unstructured":"Santos CS, Morales CM, \u00c1lvarez ED, Castro C\u00c1, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol. 2020;39(9):2789\u201396. https:\/\/doi.org\/10.1007\/s10067-020-05301-2.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1563_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.12997\/jla.2020.9.3.435","volume":"9","author":"GJ Choi","year":"2020","unstructured":"Choi GJ, Kim HM, Kang H. The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews. J Lipid Atheroscler. 2020;9(3):435\u201348. https:\/\/doi.org\/10.12997\/jla.2020.9.3.435.","journal-title":"J Lipid Atheroscler"},{"issue":"1","key":"1563_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12985-021-01604-1","volume":"18","author":"Y Liu","year":"2021","unstructured":"Liu Y, Pan Y, Yin Y, Chen W, Li X. Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis. Virol J. 2021;18(1):157. https:\/\/doi.org\/10.1186\/s12985-021-01604-1.","journal-title":"Virol J"},{"issue":"1","key":"1563_CR19","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1038\/s41598-021-86747-5","volume":"11","author":"L Masana","year":"2021","unstructured":"Masana L, Correig E, Ibarretxe D, et al. Low HDL and high triglycerides predict COVID-19 severity. Sci Rep. 2021;11(1):7217. https:\/\/doi.org\/10.1038\/s41598-021-86747-5.","journal-title":"Sci Rep"},{"issue":"2","key":"1563_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.hrtlng.2021.01.016","volume":"50","author":"\u00d6T Y\u0131ld\u0131r\u0131m","year":"2021","unstructured":"Y\u0131ld\u0131r\u0131m \u00d6T, Kaya \u015e. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. Heart Lung. 2021;50(2):329\u201333. https:\/\/doi.org\/10.1016\/j.hrtlng.2021.01.016.","journal-title":"Heart Lung"},{"key":"1563_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1136\/bmj.m1966","volume":"369","author":"CM Petrilli","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O\u2019Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new York City: prospective cohort study. BMJ. 2020;369:1966. https:\/\/doi.org\/10.1136\/bmj.m1966.","journal-title":"BMJ"},{"issue":"1","key":"1563_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12879-020-05144-x","volume":"20","author":"MC Chang","year":"2020","unstructured":"Chang MC, Park Y-K, Kim B-O, Park D. Risk factors for disease progression in COVID-19 patients. BMC Infect Dis. 2020;20(1):445. https:\/\/doi.org\/10.1186\/s12879-020-05144-x.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"1563_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/oby.22831","volume":"28","author":"A Simonnet","year":"2020","unstructured":"Simonnet A, Chetboun M, Poissy J. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195\u20139. https:\/\/doi.org\/10.1002\/oby.22831.","journal-title":"Obesity"},{"key":"1563_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2021.02.011","volume":"517","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Y, Lu R, Dai M, Shen M, Zhang J, et al. Lipid metabolism changes in patients with severe COVID-19. Clin Chim Acta. 2021;517:66\u201373. https:\/\/doi.org\/10.1016\/j.cca.2021.02.011.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"1563_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243600","volume":"15","author":"B Moazzami","year":"2020","unstructured":"Moazzami B, Chaichian S, Kasaeian A, Djalalinia S, Akhlaghdoust M, Eslami M, et al. Metabolic risk factors and risk of Covid-19: a systematic review and meta-analysis. PLoS One. 2020;15(12):e0243600. https:\/\/doi.org\/10.1371\/journal.pone.0243600.","journal-title":"PLoS One"},{"issue":"7","key":"1563_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S2213-8587(20)30160-1","volume":"8","author":"C Caussy","year":"2020","unstructured":"Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8(7):562\u20134. https:\/\/doi.org\/10.1016\/S2213-8587(20)30160-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1563_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5603\/DK.2020.0041","volume":"9","author":"M Faghir-Gangi","year":"2020","unstructured":"Faghir-Gangi M, Moameri H, Abdolmohamadi N, Nematollahi S. The prevalence of type 2 diabetes in patients with COVID-19: a systematic review and meta-analysis. Clin Diabetol. 2020;9(5):271\u20138. https:\/\/doi.org\/10.5603\/DK.2020.0041.","journal-title":"Clin Diabetol"},{"issue":"11","key":"1563_CR28","doi-asserted-by":"publisher","first-page":"e13128","DOI":"10.1111\/obr.13128","volume":"21","author":"BM Popkin","year":"2020","unstructured":"Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):e13128. https:\/\/doi.org\/10.1111\/obr.13128.","journal-title":"Obes Rev"},{"issue":"4","key":"1563_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","volume":"14","author":"A Kumar","year":"2020","unstructured":"Kumar A, Arora A, Shrama P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14(4):535\u201345. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.044.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"1563_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.25182\/jgp.2020.15.2.63-70","volume":"15","author":"H Kaur","year":"2020","unstructured":"Kaur H, Aeri BT. Assessing the prevalence of dyslipidemia in apparently healthy urban obese adults residing in South Delhi. India J Gizi Pangan. 2020;15(2):63\u201370. https:\/\/doi.org\/10.25182\/jgp.2020.15.2.63-70.","journal-title":"India J Gizi Pangan"},{"issue":"10","key":"1563_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205709","volume":"13","author":"Y Li","year":"2018","unstructured":"Li Y, Zhao L, Yu D, Ding G. The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China. PLoS One. 2018;13(10):e0205709. https:\/\/doi.org\/10.1371\/journal.pone.0205709.","journal-title":"PLoS One"},{"issue":"3","key":"1563_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5114\/aoms\/132950","volume":"17","author":"A Vahedian-Azimi","year":"2021","unstructured":"Vahedian-Azimi A, Mohammadi SM, Beni FH, Banach M, Guest PC, Jamialahmadi T, et al. Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci. 2021;17(3):579\u201395. https:\/\/doi.org\/10.5114\/aoms\/132950.","journal-title":"Arch Med Sci"},{"issue":"8","key":"1563_CR33","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1096\/fj.202001451","volume":"34","author":"AV Sorokin","year":"2020","unstructured":"Sorokin AV, Karathanasis SK, Yang Z-H, Freeman L, Kotani K, Remaley AT. COVID-19-associated dyslipidemia: implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34(8):9843\u201353. https:\/\/doi.org\/10.1096\/fj.202001451.","journal-title":"FASEB J"},{"key":"1563_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cca.2020.07.015","volume":"510","author":"X Hu","year":"2020","unstructured":"Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105\u201310. https:\/\/doi.org\/10.1016\/j.cca.2020.07.015.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1563_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","volume":"14","author":"X Wei","year":"2020","unstructured":"Wei X, Zeng W, Su J, Wan H, Yu X, Cao X, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020;14(3):297\u2013304. https:\/\/doi.org\/10.1016\/j.jacl.2020.04.008.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"1563_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12944-020-01382-9","volume":"19","author":"G Wang","year":"2020","unstructured":"Wang G, Zhang Q, Zhao X, Dong H, Wu C, Wu F, et al. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis. 2020;19(1):204. https:\/\/doi.org\/10.1186\/s12944-020-01382-9.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1563_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12879-020-05242-w","volume":"20","author":"D Wang","year":"2020","unstructured":"Wang D, Li R, Wang J, Jiang Q, Gao C, Yang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan. China: a descriptive study BMC Infect Dis. 2020;20(1):519. https:\/\/doi.org\/10.1186\/s12879-020-05242-w.","journal-title":"China: a descriptive study BMC Infect Dis"},{"issue":"10","key":"1563_CR38","doi-asserted-by":"publisher","first-page":"107666","DOI":"10.1016\/j.jdiacomp.2020.107666","volume":"34","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Wei Y, Chen M, Wan Q, Chen X. Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes. J Diabetes Complicat. 2020;34(10):107666. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107666.","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"1563_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jacl.2020.07.004","volume":"14","author":"F Fogacci","year":"2020","unstructured":"Fogacci F, Bogrhi C, Cicero AFG. Misinterpreting data in lipidology in the era of COVID-19. J Clin Lipidol. 2020;14(4):543\u20134. https:\/\/doi.org\/10.1016\/j.jacl.2020.07.004.","journal-title":"J Clin Lipidol"},{"key":"1563_CR40","doi-asserted-by":"publisher","first-page":"154243","DOI":"10.1016\/j.metabol.2020.154243","volume":"107","author":"J Fan","year":"2020","unstructured":"Fan J, Wang H, Ye G, Cao X, Xu X, Tan W, et al. Letter to the editor: low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020;107:154243. https:\/\/doi.org\/10.1016\/j.metabol.2020.154243.","journal-title":"Metabolism"},{"issue":"1","key":"1563_CR41","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41598-021-82426-7","volume":"11","author":"M Caterino","year":"2021","unstructured":"Caterino M, Gelzo M, Sol S, Fedele R, Annunziata A, Calabrese C, et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci Rep. 2021;11(1):2941. https:\/\/doi.org\/10.1038\/s41598-021-82426-7.","journal-title":"Sci Rep"},{"issue":"2","key":"1563_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s42255-020-00339-7","volume":"3","author":"D Accili","year":"2021","unstructured":"Accili D. Can COVID-19 cause diabetes? Nat Metab. 2021;3(2):123\u20135. https:\/\/doi.org\/10.1038\/s42255-020-00339-7.","journal-title":"Nat Metab"},{"issue":"8","key":"1563_CR43","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/01.ATV.0000227472.70734.ad","volume":"26","author":"CY Han","year":"2006","unstructured":"Han CY, Chiba T, Campbell JS, Fausto N, Chaisson M, Orasanu G, et al. Reciprocal and coordinate regulation of serum amyloid a versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler Thromb Vasc Biol. 2006;26(8):1806\u201313. https:\/\/doi.org\/10.1161\/01.ATV.0000227472.70734.ad.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1563_CR44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jinf.2020.03.035","volume":"80","author":"H Li","year":"2020","unstructured":"Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X, et al. Serum amyloid a is a biomarker of severe coronavirus disease and poor prognosis. J Inf Secur. 2020;80(6):646\u201355. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.035.","journal-title":"J Inf Secur"},{"key":"1563_CR45","volume-title":"Endotext","author":"KR Feingold","year":"2000","unstructured":"Feingold KR, Grunfeld C. The effect of inflammation and infection on lipids and lipoproteins. In: Endotext. South Dartmouth: MDText.com, Inc.; 2000\u20132019."},{"key":"1563_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","volume":"134","author":"CS Kow","year":"2020","unstructured":"Kow CS, Hasan SS. Meta-analysis of effect of statins in patients with COVID-19. Am J Cardiol. 2020;134:153\u20135. https:\/\/doi.org\/10.1016\/j.amjcard.2020.08.004.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1563_CR47","doi-asserted-by":"publisher","first-page":"101220","DOI":"10.1016\/j.diabet.2020.101220","volume":"47","author":"AJ Scheen","year":"2020","unstructured":"Scheen AJ. Statins and clinical outcomes with COVID-19: meta-analyses of observational studies. Diabetes Metab. 2020;47(6):101220. https:\/\/doi.org\/10.1016\/j.diabet.2020.101220.","journal-title":"Diabetes Metab"},{"issue":"4","key":"1563_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-0040-1722307","volume":"47","author":"D Onorato","year":"2021","unstructured":"Onorato D, Pucci M, Carpene G, Henry BM, Sanchis-Gomar F, Lippi G. Protective effects of statins administration in European and north American patients infected with COVID-19: a meta-analysis. Semin Thromb Hemost. 2021;47(4):392\u20139. https:\/\/doi.org\/10.1055\/s-0040-1722307.","journal-title":"Semin Thromb Hemost"},{"key":"1563_CR49","doi-asserted-by":"publisher","unstructured":"Pal R, Banerjee M, Yadav U, Bhattacharjee S. Statin use and clinical outcomes in patients with COVID-19: an updated systematic review and meta-analysis. Postgrad Med J. 2021. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139172.","DOI":"10.1136\/postgradmedj-2020-139172"},{"key":"1563_CR50","doi-asserted-by":"publisher","unstructured":"Chow R, Im J, Chiu N, et al. The protective association between statins use and adverse outcomes among COVID-19 patients: a systematic review and meta-analysis. medRxiv. https:\/\/doi.org\/10.1101\/2021.02.08.21251070.","DOI":"10.1101\/2021.02.08.21251070"},{"issue":"1","key":"1563_CR51","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/07853890.2021.1933165","volume":"53","author":"K-S Wu","year":"2021","unstructured":"Wu K-S, Lin P-C, Chen Y-S, Pan T-C, Tang P-L. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann Med. 2021;53(1):874\u201384. https:\/\/doi.org\/10.1080\/07853890.2021.1933165.","journal-title":"Ann Med"},{"issue":"3","key":"1563_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43440-021-00233-3","volume":"73","author":"H Permana","year":"2021","unstructured":"Permana H, Huang I, Purwiga A, Kusumawardhani NY, Sihite TA, Martanto E, et al. In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis. Pharmacol Rep. 2021;73(3):1\u201312. https:\/\/doi.org\/10.1007\/s43440-021-00233-3.","journal-title":"Pharmacol Rep"},{"key":"1563_CR53","doi-asserted-by":"publisher","first-page":"ofab284","DOI":"10.1093\/ofid\/ofab284","volume":"8","author":"ZA Yetmar","year":"2021","unstructured":"Yetmar ZA, Chesdachai S, Kashour T, et al. Prior statin use and risk of mortality and severe disease from coronavirus disease 2019: a systematic review and meta-analysis. Open Forum Infect Dis. 2021;8:ofab284.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"1563_CR54","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.numecd.2021.02.020","volume":"31","author":"TI Hariyanto","year":"2021","unstructured":"Hariyanto TI, Kurniawan A. Statin and outcomes of coronavirus disease 2019 (COVID-19): a systematic review, meta-analysis, and meta-regression. Nutr Metab Cardiovasc Dis. 2021;31(6):1662\u201370. https:\/\/doi.org\/10.1016\/j.numecd.2021.02.020.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1563_CR55","doi-asserted-by":"publisher","unstructured":"Zein AFMZ, Sulistiyana CS, Khasanah U, Wibowo A, Lim MA, Pranata R. Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts. Postgrad Med J. 2021. https:\/\/doi.org\/10.1136\/postgradmedj-2021-140409.","DOI":"10.1136\/postgradmedj-2021-140409"},{"key":"1563_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijid.2021.08.004","volume":"110","author":"C Diaz-Arocutipa","year":"2021","unstructured":"Diaz-Arocutipa C, Melgar-Talavera B, Alvarado-Yarasca \u00c1, Saravia-Bartra MM, Cazorla P, Belzusarri I, et al. Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients. Int J Infect Dis. 2021;110:374\u201381. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.004.","journal-title":"Int J Infect Dis"},{"key":"1563_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2021.06.911","volume":"330","author":"A Kollias","year":"2021","unstructured":"Kollias A, Kyriakoulis KG, Kyriakoulis IG, Nitsotolis T, Poulakou G, Stergiou GS, et al. Statin use and mortality in COVID-19 patients: updated systematic review and meta-analysis. Atherosclerosis. 2021;330:114\u201321. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.06.911.","journal-title":"Atherosclerosis"},{"key":"1563_CR58","doi-asserted-by":"publisher","unstructured":"Kow CS, Hasan SS. The association between the use of statins and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. Am J Cardiovasc Drugs. 2021:1\u201315. https:\/\/doi.org\/10.1007\/s40256-021-00490-w.","DOI":"10.1007\/s40256-021-00490-w"},{"key":"1563_CR59","first-page":"175","volume":"41","author":"H-Y Lee","year":"2021","unstructured":"Lee H-Y, Ahn J, Park J, et al. Beneficial effect of statins in COVID-19-related outcomes-brief report: a national population-based cohort study. Arterioscler Thromb Vasc Biol. 2021;41:175\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"1563_CR60","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11739-020-02504-y","volume":"15","author":"R Rossi","year":"2020","unstructured":"Rossi R, Talarico M, Coppi F, Boriani G. Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action. Intern Emerg Med. 2020;15(8):1573\u20136. https:\/\/doi.org\/10.1007\/s11739-020-02504-y.","journal-title":"Intern Emerg Med"},{"issue":"2","key":"1563_CR61","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.diabet.2020.10.001","volume":"47","author":"B Cariou","year":"2021","unstructured":"Cariou B, Goronflot T, Rimbert A, Boullu S, le May C, Moulin P, et al. Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study. Diabetes Metab. 2021;47(2):101202. https:\/\/doi.org\/10.1016\/j.diabet.2020.10.001.","journal-title":"Diabetes Metab"},{"issue":"7304","key":"1563_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","volume":"323","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323(7304):101\u20135. https:\/\/doi.org\/10.1136\/bmj.323.7304.101.","journal-title":"BMJ"},{"issue":"9","key":"1563_CR63","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/j.numecd.2021.06.009","volume":"31","author":"JR Tandaju","year":"2021","unstructured":"Tandaju JR, Ii W, Barati-Boldaji R, Raeisi-Dehkordi H. Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19): reconsideration is needed. Nutr Metab Cardiovasc Dis. 2021;31(9):2737\u20139. https:\/\/doi.org\/10.1016\/j.numecd.2021.06.009.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"1563_CR64","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.numecd.2021.06.008","volume":"31","author":"TI Hariyanto","year":"2021","unstructured":"Hariyanto TI, Kurniawan A. Authors\u2019 response: meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19). Nutr Metab Cardiovasc Dis. 2021;31(9):2740\u20132. https:\/\/doi.org\/10.1016\/j.numecd.2021.06.008.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1563_CR65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2020.09.008","volume":"313","author":"Z Iqbal","year":"2020","unstructured":"Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, et al. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: an expert panel position statement from HEART UK. Atherosclerosis. 2020;313:126\u201336. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.09.008.","journal-title":"Atherosclerosis"},{"key":"1563_CR66","doi-asserted-by":"crossref","unstructured":"Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, et al. Lipid-modulating agents for prevention or treatment of COVID-19 in randomized trials. medRxiv. 2021:2021.05.03.21256468.","DOI":"10.1101\/2021.05.03.21256468"},{"issue":"1","key":"1563_CR67","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","volume":"7","author":"Q Wu","year":"2017","unstructured":"Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110. https:\/\/doi.org\/10.1038\/s41598-017-09536-z.","journal-title":"Sci Rep"},{"issue":"17-18","key":"1563_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00508-021-01845-8","volume":"133","author":"F Ferrara","year":"2021","unstructured":"Ferrara F, Vitiello A. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection. Wien Klin Wochenschr. 2021;133(17-18):1\u20138. https:\/\/doi.org\/10.1007\/s00508-021-01845-8.","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"1563_CR69","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.3390\/ijms22084177","volume":"22","author":"A Pawlos","year":"2021","unstructured":"Pawlos A, Niedzielski M, Gorzelak-Pabi\u015b P, Broncel M, Wo\u017aniak E. COVID-19: direct and indirect mechanisms of statins. Int J Mol Sci. 2021;22(8):4177. https:\/\/doi.org\/10.3390\/ijms22084177.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1563_CR70","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875\u20139. https:\/\/doi.org\/10.1038\/nm1267.","journal-title":"Nat Med"},{"key":"1563_CR71","first-page":"344","volume":"369","author":"Y Lu","year":"2008","unstructured":"Lu Y, Liu DX, Tam JP. Lipid rafts are involved in SARS-CoV entry into vero E6 cells. Biochem. Biophys. Res Commun. 2008;369:344\u20139.","journal-title":"Res Commun"},{"issue":"1","key":"1563_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.23750\/abm.v91i1.9402","volume":"91","author":"M Baglivo","year":"2020","unstructured":"Baglivo M, Baronio M, Natalini G, Beccari T, Chiurazzi P, Fulcheri E, et al. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? Acta Biomed. 2020;91(1):161\u20134. https:\/\/doi.org\/10.23750\/abm.v91i1.9402.","journal-title":"Acta Biomed"},{"issue":"3","key":"1563_CR73","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5114\/aoms.2020.94655","volume":"16","author":"\u017d Reiner","year":"2020","unstructured":"Reiner \u017d, Hatamipour M, Banach M, Pirro M, Al-Rasadi K, Jamialahmadi T, et al. Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci. 2020;16(3):490\u20136. https:\/\/doi.org\/10.5114\/aoms.2020.94655.","journal-title":"Arch Med Sci"},{"key":"1563_CR74","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.12688\/f1000research.26359.1","volume":"9","author":"K Baby","year":"2020","unstructured":"Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. Targeting SARS-CoV-2 RNA-dependent RNA polymerase: an in silico drug repurposing for COVID-19. F1000Res. 2020;9:1166.","journal-title":"F1000Res"},{"issue":"6","key":"1563_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1\u20139. https:\/\/doi.org\/10.1002\/rmv.2141.","journal-title":"Rev Med Virol"},{"issue":"1","key":"1563_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40272-019-00367-1","volume":"22","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Cron RQ. Macrophage activation syndrome and secondary Hemophagocytic Lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management. Pediatr Drugs. 2020;22(1):29\u201344. https:\/\/doi.org\/10.1007\/s40272-019-00367-1.","journal-title":"Pediatr Drugs"},{"issue":"6","key":"1563_CR77","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/1755-5922.12150","volume":"33","author":"KO Bonsu","year":"2015","unstructured":"Bonsu KO, Reidpath DD, Kadirvelu A. Effects of statin treatment on inflammation and cardiac function in heart failure: an adjusted indirect comparison Meta-analysis of randomized trials. Cardiovasc Ther. 2015;33(6):338\u201346. https:\/\/doi.org\/10.1111\/1755-5922.12150.","journal-title":"Cardiovasc Ther"},{"key":"1563_CR78","first-page":"49","volume":"27","author":"P Chansrichavala","year":"2009","unstructured":"Chansrichavala P, Chantharaksri U, Sritara P, Chaiyaroj SC. Atorvastatin attenuates TLR4-mediated NF-\u03baB activation in a MyD88-dependent pathway. Asian Pac J Allergy Immunol. 2009;27:49\u201357.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"1563_CR79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/mol.116.108100","volume":"92","author":"S Wang","year":"2017","unstructured":"Wang S, Xie X, Lei T, Zhang K, Lai B, Zhang Z, et al. Statins attenuate activation of the NLRP3 Inflammasome by oxidized LDL or TNF<i>\u03b1<\/i> in vascular endothelial cells through a PXR-dependent mechanism. Mol Pharmacol. 2017;92(3):256\u201364. https:\/\/doi.org\/10.1124\/mol.116.108100.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1563_CR80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2014.12.014","volume":"238","author":"E Oikonomou","year":"2015","unstructured":"Oikonomou E, Siasos G, Zaromitidou M, Hatzis G, Mourouzis K, Chrysohoou C, et al. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients. Atherosclerosis. 2015;238(2):159\u201364. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.014.","journal-title":"Atherosclerosis."},{"issue":"4","key":"1563_CR81","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.2020006520","volume":"136","author":"H Al-Samkari","year":"2020","unstructured":"Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489\u2013500. https:\/\/doi.org\/10.1182\/blood.2020006520.","journal-title":"Blood"},{"issue":"24","key":"1563_CR82","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/eurheartj\/eht046","volume":"34","author":"S Biere-Rafi","year":"2013","unstructured":"Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A, et al. Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J. 2013;34(24):1800\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/eht046.","journal-title":"Eur Heart J"},{"issue":"1","key":"1563_CR83","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1160\/TH15-10-0770","volume":"116","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Catena C, Ray KK, Vallejo-Vaz AJ, Reiner \u017d, Sechi LA, et al. Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1. A systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2016;116(1):162\u201371. https:\/\/doi.org\/10.1160\/TH15-10-0770.","journal-title":"Thromb Haemost"},{"issue":"03","key":"1563_CR84","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1160\/th15-08-0620","volume":"115","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials. Thromb Haemost. 2016;115(03):520\u201332. https:\/\/doi.org\/10.1160\/th15-08-0620.","journal-title":"Thromb Haemost"},{"issue":"1","key":"1563_CR85","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12879-021-05984-1","volume":"21","author":"G Li","year":"2021","unstructured":"Li G, Du L, Cao X, et al. Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients. BMC Infect Dis. 2021;21(1):299. https:\/\/doi.org\/10.1186\/s12879-021-05984-1.","journal-title":"BMC Infect Dis"},{"key":"1563_CR86","first-page":"PA991","volume":"52","author":"M Yildirim","year":"2018","unstructured":"Yildirim M, Kayalar O, Atahan E, Oztay F. Anti-fibrotic effect of atorvastatin on the lung fibroblasts and myofibroblasts. Eur Resp J. 2018;52:PA991.","journal-title":"Eur Resp J"},{"issue":"8","key":"1563_CR87","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/ijms19082460","volume":"19","author":"A Saito","year":"2018","unstructured":"Saito A, Horie M, Nagase T. TGF-\u03b2 signaling in lung health and disease. Int J Mol Sci. 2018;19(8):2460. https:\/\/doi.org\/10.3390\/ijms19082460.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1563_CR88","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1159\/000350104","volume":"31","author":"T Yang","year":"2013","unstructured":"Yang T, Chen M, Sun T. Simvastatin attenuates TGF-\u03b21-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem. 2013;31(6):863\u201374. https:\/\/doi.org\/10.1159\/000350104.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"1563_CR89","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.archoralbio.2013.03.002","volume":"58","author":"S Saewong","year":"2013","unstructured":"Saewong S, Thammasitboon K, Wattanaroonwong N. Simvastatin induces apoptosis and disruption of the actin cytoskeleton in human dental pulp cells and periodontal ligament fibroblasts. Arch Oral Biol. 2013;58(8):964\u201374. https:\/\/doi.org\/10.1016\/j.archoralbio.2013.03.002.","journal-title":"Arch Oral Biol"},{"issue":"3","key":"1563_CR90","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/nur.20187","volume":"30","author":"R-P Lee","year":"2007","unstructured":"Lee R-P, Lin N-T, Chao Y-FC, Lin C-C, Harn H-J, Chen H-I. High-density lipoprotein prevents organ damage in endotoxemia. Res Nurs Health. 2007;30(3):250\u201360. https:\/\/doi.org\/10.1002\/nur.20187.","journal-title":"Res Nurs Health"},{"issue":"2","key":"1563_CR91","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0022-2275(20)33363-0","volume":"40","author":"C Grunfeld","year":"1999","unstructured":"Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, Feingold KR. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res. 1999;40(2):245\u201352. https:\/\/doi.org\/10.1016\/S0022-2275(20)33363-0.","journal-title":"J Lipid Res"},{"issue":"25","key":"1563_CR92","doi-asserted-by":"publisher","first-page":"17947","DOI":"10.1074\/jbc.M112.442699","volume":"288","author":"L Guo","year":"2013","unstructured":"Guo L, Ai J, Zheng Z, Howatt DA, Daugherty A, Huang B, et al. High density lipoprotein protects against polymicrobe-induced sepsis in mice. J Biol Chem. 2013;288(25):17947\u201353. https:\/\/doi.org\/10.1074\/jbc.M112.442699.","journal-title":"J Biol Chem"},{"issue":"12","key":"1563_CR93","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1194\/jlr.E033407","volume":"53","author":"KR Feingold","year":"2012","unstructured":"Feingold KR, Grunfeld C. Lipids: a key player in the battle between the host and microorganisms. J Lipid Res. 2012;53(12):2487\u20139. https:\/\/doi.org\/10.1194\/jlr.E033407.","journal-title":"J Lipid Res"},{"issue":"11","key":"1563_CR94","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/ijms22115980","volume":"22","author":"A Stasi","year":"2021","unstructured":"Stasi A, Franzin R, Fiorentino M, Squiccimarro E, Castellano G, Gesualdo L. Multifaced roles of HDL in sepsis and SARS-CoV-2 infection: renal implications. Int J Mol Sci. 2021;22(11):5980. https:\/\/doi.org\/10.3390\/ijms22115980.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1563_CR95","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00228-020-02941-w","volume":"76","author":"M Hoxha","year":"2020","unstructured":"Hoxha M. What about COVID-19 and arachidonic acid pathway? Eur J Clin Pharmacol. 2020;76(11):1501\u20134. https:\/\/doi.org\/10.1007\/s00228-020-02941-w.","journal-title":"Eur J Clin Pharmacol"},{"key":"1563_CR96","doi-asserted-by":"publisher","unstructured":"Das UN. Bioactive lipids-based therapeutic approach to COVID-19 and other similar infections. Arch Med Sci. 2021; in press. https:\/\/doi.org\/10.5114\/aoms\/135703.","DOI":"10.5114\/aoms\/135703"},{"issue":"2","key":"1563_CR97","first-page":"88","volume":"11","author":"P Ris\u00e9","year":"2001","unstructured":"Ris\u00e9 P, Pazzucconi F, Sirtori CR, Galli C. Statins enhance arachidonic acid synthesis in hypercholesterolemic patients. Nutr Metab Cardiovasc Dis. 2001;11(2):88\u201394.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"1563_CR98","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1038\/s41598-021-84850-1","volume":"11","author":"A Goc","year":"2021","unstructured":"Goc A, Niedzwiecki A, Rath M. Polyunsaturated \u03c9-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci Rep. 2021;11(1):5207. https:\/\/doi.org\/10.1038\/s41598-021-84850-1.","journal-title":"Sci Rep"},{"key":"1563_CR99","doi-asserted-by":"publisher","first-page":"104891","DOI":"10.1016\/j.phrs.2020.104891","volume":"158","author":"M Banach","year":"2020","unstructured":"Banach M, Penson P, Fras Z, Vrablik M, Pella D, Reiner \u017d, et al. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacol Res. 2020;158:104891. https:\/\/doi.org\/10.1016\/j.phrs.2020.104891.","journal-title":"Pharmacol Res"},{"key":"1563_CR100","unstructured":"Andreini D, Arbelo E, Barbato E, et al. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance"},{"key":"1563_CR101","doi-asserted-by":"publisher","unstructured":"Banach M, Burchardt P, Chlebus K, et al. PoLA\/CFPiP\/PCS\/PSLD\/PSD\/PSH guidelines on the diagnosis and tehrapy of lipid disorders in Poland. Arch Med Sci. 2021;17(6). https:\/\/doi.org\/10.5114\/aoms\/141941.","DOI":"10.5114\/aoms\/141941"},{"issue":"6","key":"1563_CR102","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.dsx.2020.10.021","volume":"14","author":"MM Minz","year":"2020","unstructured":"Minz MM, Bansal M, Kasliwal RR. Statins and SARS-CoV-2 disease: current concepts and possible benefits. Diabetes Metab Syndr. 2020;14(6):2063\u20137. https:\/\/doi.org\/10.1016\/j.dsx.2020.10.021.","journal-title":"Diabetes Metab Syndr"},{"key":"1563_CR103","doi-asserted-by":"publisher","unstructured":"Vahedian-Azimi A, Mohammadi SM, Banach M, et al. Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis. Biomed Res Int. 2021;2021:1901772. https:\/\/doi.org\/10.1155\/2021\/1901772.\u00a0","DOI":"10.1155\/2021\/1901772"},{"key":"1563_CR104","doi-asserted-by":"crossref","unstructured":"Israel A, Sch\u00e4ffer AA, Cicurel A, et al. Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population. medRxiv. 2021:2020.10.13.20211953.","DOI":"10.7554\/eLife.68165"},{"key":"1563_CR105","doi-asserted-by":"publisher","first-page":"110452","DOI":"10.1016\/j.mehy.2020.110452","volume":"146","author":"A Barkas","year":"2021","unstructured":"Barkas A, Milionis H, Anastasiou G, Liberopoulos S. Statins and PCSK9 inhibitors: what is their role in coronavirus disease 2019? Med Hypotheses. 2021;146:110452. https:\/\/doi.org\/10.1016\/j.mehy.2020.110452.","journal-title":"Med Hypotheses"},{"issue":"13","key":"1563_CR106","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/1873-3468.13152","volume":"592","author":"Z Li","year":"2018","unstructured":"Li Z, Liu Q. Proprotein convertase subtilisin\/kexin type 9 inhibits interferon \u03b2 expression through interacting with ATF-2. FEBS Lett. 2018;592(13):2323\u201333. https:\/\/doi.org\/10.1002\/1873-3468.13152.","journal-title":"FEBS Lett"},{"issue":"5","key":"1563_CR107","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/joim.13210","volume":"289","author":"A Vuorio","year":"2021","unstructured":"Vuorio A, Kovanen PT. PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia. J Intern Med. 2021;289(5):749\u201351. https:\/\/doi.org\/10.1111\/joim.13210.","journal-title":"J Intern Med"},{"key":"1563_CR108","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.amjcard.2020.10.026","volume":"138","author":"N Katsiki","year":"2021","unstructured":"Katsiki N, Banach M, Mikhailidis DP. More good news on statins and COVID-19. Am J Cardiol. 2021;138:127\u20138.","journal-title":"Am J Cardiol"},{"key":"1563_CR109","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","volume":"11","author":"S Bhaskar","year":"2020","unstructured":"Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, et al. Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. https:\/\/doi.org\/10.3389\/fimmu.2020.01648.","journal-title":"Front Immunol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01563-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01563-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01563-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T23:16:09Z","timestamp":1635117369000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01563-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01563-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declared that he has no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}